Lyka Labs gains on entering into loan agreement with IARC

22 Nov 2019 Evaluate

Lyka Labs is currently trading at Rs. 17.20, up by 0.05 points or 0.29% from its previous closing of Rs. 17.15 on the BSE.

The scrip opened at Rs. 17.75 and has touched a high and low of Rs. 17.75 and Rs. 17.20 respectively.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 35.25 on 02-Apr-2019 and a 52 week low of Rs. 14.60 on 15-Oct-2019.

Last one week high and low of the scrip stood at Rs. 19.50 and Rs. 16.80 respectively. The current market cap of the company is Rs. 50.92 crore.

The promoters holding in the company stood at 19.88%, while Institutions and Non-Institutions held 4.15% and 75.97% respectively.

Lyka Labs has entered into loan agreement with International Asset Reconstruction Company (IARC) for restructuring of loans taken from Dena Bank and Kapol Cooperative Bank and additional project finance & working capital loan. The company has executed loan agreement on November 20, 2019.

Lyka Labs (Lyka) is an India-based healthcare company. The Company is manufacture of lyophilized products. The primary segment of the company is business segment, which consists of pharmaceutical products /pharma related services.

Lyka Labs Share Price

78.32 -2.72 (-3.36%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×